Literature DB >> 19802037

Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic GVHD.

P M K Tam, A L Young, L L Cheng, P T H Lam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19802037     DOI： 10.1038/bmt.2009.249

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

Review 1.  Cutaneous graft-versus-host disease--clinical considerations and management.

Authors:  Peggy A Wu; Edward W Cowen
Journal:  Curr Probl Dermatol       Date:  2012-02-17

Review 2.  Graft versus host disease: clinical evaluation, diagnosis and management.

Authors:  Edgar M Espana; Sejal Shah; Marcony R Santhiago; Arun D Singh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-17       Impact factor: 3.117

3.  Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.

Authors:  Kyung-Sun Na; Man Soo Kim
Journal:  J Ocul Pharmacol Ther       Date:  2012-06-25       Impact factor: 2.671

4.  Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops.

Authors:  Empar Sanz-Marco; Patricia Udaondo; Salvador García-Delpech; Amparo Vazquez; Manuel Diaz-Llopis
Journal:  J Ocul Pharmacol Ther       Date:  2013-08-15       Impact factor: 2.671

5.  Refractory recurrent ocular graft versus host disease.

Authors:  Emily Greenan; Elisabeth Vandenberghe; Conor C Murphy
Journal:  BMJ Case Rep       Date:  2019-12-15

Review 6.  Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations.

Authors:  Nariman Nassiri; Medi Eslani; Nekoo Panahi; Shiva Mehravaran; Alireza Ziaei; Ali R Djalilian
Journal:  J Ophthalmic Vis Res       Date:  2013-10

Review 7.  Dry eye: an inflammatory ocular disease.

Authors:  Michelle Hessen; Esen Karamursel Akpek
Journal:  J Ophthalmic Vis Res       Date:  2014-04

Review 8.  Topical tacrolimus in anterior segment inflammatory disorders.

Authors:  Samir S Shoughy
Journal:  Eye Vis (Lond)       Date:  2017-03-09

9.  Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop.

Authors:  Xurxo García-Otero; Victoria Díaz-Tomé; Rubén Varela-Fernández; Manuel Martín-Pastor; Miguel González-Barcia; José Blanco-Méndez; Cristina Mondelo-García; Maria A Bermudez; Francisco Gonzalez; Pablo Aguiar; Anxo Fernández-Ferreiro; Francisco J Otero-Espinar
Journal:  Pharmaceutics       Date:  2021-01-23       Impact factor: 6.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.